Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial

By Pandina Gahan   Bossie Cynthia   Youssef Eriene   Zhu Young   Dunbar Fiona  

Journal of Autism and Developmental Disorders, Vol. 37, Iss. 2, 2007-02 ,pp. : 367-373

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

By Olie J.   Gunn K.   Katz E.  

European Psychiatry, Vol. 12, Iss. 1, 1997-01 ,pp. : 34-41

Elsevier

Access to resources Recommend Favorite